Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
The Journal of Urology
|
June 10, 2022
A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information System
Braden Millan, Rodney H Breau, Bimal Bhindi, et al.
Urologic Oncology
|
July 10, 2019
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis
Madhur Nayan, Shreya Jalali, Anil Kapoor, et al.
Urologic Oncology
|
August 12, 2020
Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience
Alice Dragomir, Sara Nazha, Lori A Wood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
April 25, 2018
Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces
Dixon T S Woon, Thenappan Chandrasekar, Lorne Aaron, et al.
European Urology
|
May 13, 2017
Setting Research Priorities for Kidney Cancer
Jennifer M Jones, Jaimin Bhatt, Jonathan Avery, et al.
Clinical Genitourinary Cancer
|
March 23, 2024
Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis)
Jeffrey Graham, Sunita Ghosh, Rodney H Breau, et al.
Clinical Genitourinary Cancer
|
May 1, 2026
Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World Analysis
Braden Millan, Sunita Ghosh, Naveen S Basappa, et al.
Cancer Reports (Hoboken, N.J.)
|
December 14, 2022
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma
Ambica Parmar, Sunita Ghosh, Arjun Sahgal, et al.
Clinical Genitourinary Cancer
|
February 4, 2022
Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients
Myuran Thana, Naveen S Basappa, Sunita Ghosh, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 19, 2017
First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience
Aly-Khan A Lalani, Haocheng Li, Daniel Y C Heng, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
The Journal of Urology
|
June 10, 2022
A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information System
Braden Millan, Rodney H Breau, Bimal Bhindi, et al.
Urologic Oncology
|
July 10, 2019
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis
Madhur Nayan, Shreya Jalali, Anil Kapoor, et al.
Urologic Oncology
|
August 12, 2020
Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience
Alice Dragomir, Sara Nazha, Lori A Wood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
April 25, 2018
Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces
Dixon T S Woon, Thenappan Chandrasekar, Lorne Aaron, et al.
European Urology
|
May 13, 2017
Setting Research Priorities for Kidney Cancer
Jennifer M Jones, Jaimin Bhatt, Jonathan Avery, et al.
Clinical Genitourinary Cancer
|
March 23, 2024
Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis)
Jeffrey Graham, Sunita Ghosh, Rodney H Breau, et al.
Clinical Genitourinary Cancer
|
May 1, 2026
Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World Analysis
Braden Millan, Sunita Ghosh, Naveen S Basappa, et al.
Cancer Reports (Hoboken, N.J.)
|
December 14, 2022
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma
Ambica Parmar, Sunita Ghosh, Arjun Sahgal, et al.
Clinical Genitourinary Cancer
|
February 4, 2022
Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients
Myuran Thana, Naveen S Basappa, Sunita Ghosh, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 19, 2017
First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience
Aly-Khan A Lalani, Haocheng Li, Daniel Y C Heng, et al.
Page
of 6